financetom
Technology
financetom
/
Technology
/
eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency
Mar 24, 2026 6:19 AM

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

BOSTON--(BUSINESS WIRE)--

eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that argenx SE, a global immunology company, is expanding adoption of the elluminate Clinical Data Cloud® to improve and enhance clinical data processes.

The elluminate platform is designed to improve access to and analysis of clinical trial data across sources with a central source of communication for clinical data, including Data Central for collaborative data review across sources, Clinical Analytics for self-service data visualization and analysis, Sample Management Analytics for tracking of external data, and Protocol Deviations for trial oversight and compliance. elluminate eIQ Review, an AI-enabled data review and query automation system, and machine learning (ML)-driven Audit Trail Review integrates more advanced capabilities. This approach aims to help reduce cycle times through improved data quality.

“We’re excited to continue supporting argenx’s commitment to future-proofing clinical trials with a modern data infrastructure,” says Raj Indupuri, CEO and co-founder at eClinical Solutions. "The expanded collaboration will aid argenx in innovating their data operations, enhance collaboration and data quality, and accelerate time to market in support of their vision to reach more patients with breakthrough science.”

For more information on eClinical Solutions’ AI-enabled elluminate platform, click here.

About eClinical Solutions LLC

eClinical Solutions’ industry-leading clinical data intelligence platform, elluminate®, and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow’s breakthroughs with today’s resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work® India Certification™. Learn more at http://www.eclinicalsol.com/ and follow eClinical Solutions on LinkedIn.

Source: eClinical Solutions LLC

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadpin Wins 2025 Oracle Global Service Partner Tech/Cloud Customer Success Award
Broadpin Wins 2025 Oracle Global Service Partner Tech/Cloud Customer Success Award
Nov 3, 2025
Award celebrates consulting firm's excellence in delivering transformative Oracle solutions for global enterprises LAS VEGAS, Nov. 3, 2025 /PRNewswire/ -- Broadpin, a global Oracle consulting leader formed from the unification of Project Partners, PROMATIS, Quistor, and PITSS, has been named the Winner of the 2025 Oracle Global Service Partner Tech/Cloud Customer Success Award. The recognition was announced during the Oracle...
CMS Energy Announces Proposed Offering of $750 million of Convertible Senior Notes Due 2031
CMS Energy Announces Proposed Offering of $750 million of Convertible Senior Notes Due 2031
Nov 3, 2025
JACKSON, Mich., Nov. 3, 2025 /PRNewswire/ -- CMS Energy Corporation ( CMS/PB ) announced today that it intends to offer, subject to market and other conditions, $750 million aggregate principal amount of its convertible senior notes due 2031 (the convertible notes) in a private placement under the Securities Act of 1933, as amended (the Securities Act). CMS Energy ( CMS/PB...
Expert Outlook: Strategy Through The Eyes Of 11 Analysts
Expert Outlook: Strategy Through The Eyes Of 11 Analysts
Nov 3, 2025
Strategy has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 8 2 1 0...
What 9 Analyst Ratings Have To Say About Canadian Solar
What 9 Analyst Ratings Have To Say About Canadian Solar
Nov 3, 2025
Canadian Solar ( CSIQ ) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...
Copyright 2023-2026 - www.financetom.com All Rights Reserved